Skip to main content
Premium Trial:

Request an Annual Quote

Vizgen Raises $37M in Series B Financing

NEW YORK – Spatial genomics startup Vizgen said on Thursday that it has raised $37 million in an oversubscribed Series B financing.

Novalis LifeSciences and Northpond Ventures led the round, joined by new investors Tao Capital Partners, Pura Vida Investments, and an unspecified US endowment fund as well as existing investors Arch Venture Partners and David Walt. Walt, a professor at Harvard Medical School, is a Vizgen cofounder and board member.

In a statement, Vizgen said it would use the proceeds "to grow to support commercialization and increase its manufacturing capacity" for its Merscope spatial transcriptomics technology.

The Harvard spinout is commercializing multiplexed error-robust fluorescence in situ hybridization (MERFISH) technology developed in Xiaowei Zhuang's lab. It raised $14 million in Series A financing in January 2020.

Novalis LifeSciences chairman and former Bayer and Thermo Fisher Scientific CEO Marijn Dekkers will join Vizgen's board. He is also chairman of the board at Ginkgo Bioworks.

According to its website, Novalis LifeSciences has also invested in Ginkgo, Quanterix, and Decipher Biosciences.

In 2021 alone, Northpond Ventures has participated in funding rounds for Scipher Medicine, Inflammatix, Personal Genome Diagnostics, Syapse, Encodia, and Delfi Diagnostics. Tao Capital also invested in Encodia.

"Funding from this Series B will enable us to bring the best tools for in situ single cell spatial genomics to the research community faster," Vizgen CEO Terry Lo said in a statement. "We are grateful to have such supportive investors and founders to help realize this mission."

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.